A clinical trial to study the effects of Aripiprazole in Risperidone induced increased prolactin level and its consequences.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Schizophrenia
- Registration Number
- CTRI/2012/11/003114
- Lead Sponsor
- ICMR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patients with Schizophrenia who were maintaing well on Tab Risperidone atleast 4 mg for the minimum duration of 12 weeks
Exclusion Criteria
Patient who is having serious medical illness
Patient who is having seizure disorder
Patient who requires dose modification
Patients who were not able to give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method